Production (Stage)
PDS Biotechnology Corporation
PDSB
$1.69
$0.138.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -35.50M | -37.61M | -40.56M | -40.68M | -43.89M |
| Total Depreciation and Amortization | 60.40K | 59.70K | 59.00K | 58.30K | 57.60K |
| Total Amortization of Deferred Charges | 1.16M | 1.16M | 1.12M | 972.50K | 800.20K |
| Total Other Non-Cash Items | 6.94M | 7.12M | 7.24M | 7.57M | 8.29M |
| Change in Net Operating Assets | -6.79M | -5.75M | -3.11M | -2.35M | 4.36M |
| Cash from Operations | -34.12M | -35.03M | -35.25M | -34.43M | -30.39M |
| Capital Expenditure | -29.00K | -29.00K | -29.00K | -29.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -29.00K | -29.00K | -29.00K | -29.00K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -6.31M | -3.18M | -54.60K | -53.40K | -52.20K |
| Issuance of Common Stock | 10.64M | 23.37M | 30.84M | 31.62M | 31.87M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3.16M | -- | -- | -- | -- |
| Cash from Financing | 7.50M | 20.19M | 30.78M | 31.57M | 31.82M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -26.66M | -14.87M | -4.50M | -2.89M | 1.44M |